Raffaele Colombo, Director, Medicinal Chemistry at Zymeworks, shared on LinkedIn:
“End of a really busy week with conferences across two continents!
Last Friday, I had the pleasure to speak at the 2026 Anticancer Developmental Therapeutics Symposium (read more) in Toronto, discussing the future of ADCs.
Lillian Siu, Philippe Bedard, and the DDP team put together a fantastic program (and even more fantastic was the Canadian hospitality)!
This week we had ENASymp26, the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (aka the ‘Triple Meeting’, organized by the EORTC – European Organisation for Research and Treatment of Cancer, National Cancer Institute (NCI), and American Association for Cancer Research) in Barcelona!
RAS definitely took over Barcelona!
The ADC plenary was also very well attended. I had the opportunity to discuss how the field is expanding beyond conventional cytotoxic payloads, including the rationale and development of targeted therapy payloads for ADCs.
These included emerging pan-RAS, pan-KRAS, and PI3K/PIKK inhibitors, as well as targeted therapies as part of dual-payload ADC approaches.
It was a real pleasure to work with my co-chair Alex Spira and share the stage with Nicole Biber, Aditya Bardia, and Paolo Tarantino.
During ENA triple meeting, we held the AACR Chemistry in Cancer Research (AACRCICR) Working Group Town Hall.
I had the easy job of chairing the session, with truly exceptional talks by Krzysztof Brzozka, Sanne Glad, and Jordi Rodón on PRMT5 inhibitors, bringing together perspectives from drug discovery through clinical development!
I’m also very very happy that we were able to squeeze in a seminar at Vall d’Hebron Institute of Oncology (VHIO) just before the ENA triple meeting, where I shared some of the lessons learned and ongoing challenges in ADC development with a fantastic team of clinicians who have helped advance this class of drugs.
A big thank you to Elena Garralda Cabanas for making it happen!
At the end of it all, I was literally speechless (having almost completely lost my voice!), but thoroughly enjoyed every discussion, debate, and exchange.
Looking forward to more weeks like this!”

You can also read:
